Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5667a1825cda92fdaac7e36f4cb4193 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-07 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R1-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R1-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-742 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-18 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-07 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-742 |
filingDate |
2017-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f95e0aa8c689374beb8adf34774c85c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d613b67349d5b64a7a101fa3b5d2156c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ffe426cc7c9b363b9fb2a0b8f662641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_239922aad8ade0a2743bbb0ddaa8e263 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d21699a5276a6ee103e4215b6243074 |
publicationDate |
2020-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10702560-B2 |
titleOfInvention |
Antibiotic sensitive Bacillus strains having antimicrobial effect against E. coli and Clostridium perfringens and having high sporulation capacity |
abstract |
A Bacillus strain characterized by (i): sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline and chloramphenicol antimicrobial activity against E. coli and Clostridium perfringens; and (iii) a sporulation percentage of at least 80 when measured after 2 days of incubation. The invention further relates to a method for selecting such strains. Many of the identified strains according to the invention are of the species Bacillus amyloliquefaciens. Some of the Bacillus amyloliquefaciens were further identified as Bacillus amyloliquefaciens subsp. amyloliquefaciens whereas others were identified as amyloliquefaciens subsp. plantarum. A Bacillus strain of the invention may be used as a feed additive to animal feed where it has a probiotic effect. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109619283-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112760251-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000049-B2 |
priorityDate |
2012-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |